Education
About Us
Working with TipRanks
Follow Us
Valiant Laboratories Ltd. (IN:VALIANTLAB)
:VALIANTLAB
VALIANTLAB Stock Chart & Stats
₹82.96
-₹2.57(-2.33%)
At close: 4:00 PM EST
₹82.96
-₹2.57(-2.33%)
Day’s Range― - ―
52-Week Range₹70.41 - ₹126.97
Previous CloseN/A
Volume41.92K
Average Volume (3M)3.75K
Market Cap
₹4.51B
Enterprise ValueN/A
Total Cash (Recent Filing)₹759.91M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)3018.2
Beta0.78
Next Earnings
Nov 10, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.39
Shares Outstanding54,312,500
10 Day Avg. Volume998
30 Day Avg. Volume3,749
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)1.46
Price to Sales (P/S)2.47
P/FCF Ratio-3.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Valiant Laboratories Ltd. News
VALIANTLAB FAQ
What was Valiant Laboratories Ltd.’s price range in the past 12 months?
Valiant Laboratories Ltd. lowest stock price was ₹70.41 and its highest was ₹126.97 in the past 12 months.
What is Valiant Laboratories Ltd.’s market cap?
Valiant Laboratories Ltd.’s market cap is ₹4.51B.
When is Valiant Laboratories Ltd.’s upcoming earnings report date?
Valiant Laboratories Ltd.’s upcoming earnings report date is Nov 10, 2025 which is in 6 days.
How were Valiant Laboratories Ltd.’s earnings last quarter?
Valiant Laboratories Ltd. released its earnings results on Aug 08, 2025. The company reported ₹0.389 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.389.
Is Valiant Laboratories Ltd. overvalued?
According to Wall Street analysts Valiant Laboratories Ltd.’s price is currently Overvalued.
Does Valiant Laboratories Ltd. pay dividends?
Valiant Laboratories Ltd. does not currently pay dividends.
What is Valiant Laboratories Ltd.’s EPS estimate?
Valiant Laboratories Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Valiant Laboratories Ltd. have?
Valiant Laboratories Ltd. has 54,312,500 shares outstanding.
What happened to Valiant Laboratories Ltd.’s price movement after its last earnings report?
Valiant Laboratories Ltd. reported an EPS of ₹0.389 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.924%.
Which hedge fund is a major shareholder of Valiant Laboratories Ltd.?
Currently, no hedge funds are holding shares in IN:VALIANTLAB
Company Description
Valiant Laboratories Ltd.
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP.
Technical Analysis
Alpa Laboratories Limited
―
Biofil Chemicals & Pharmaceuticals Ltd.
―
Krebs Biochemicals & Industries Ltd.
―
Lasa Supergenerics Ltd.
―
Vivimed Labs Limited
―